Single‐dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Open Access
- 19 February 2008
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 38 (3) , 732-741
Abstract
Simian adenoviral vectors (SAd) offer an attractive alternative to standard human adenovirus serotype 5 (AdH5) subunit vaccination, due to pre‐existing immunity affecting vaccine performance. We have used a mouse model of liver‐stage malaria to test the efficiency of three chimpanzee‐origin adenoviral vectors, AdC6, AdC7 and AdC9 containing ME.TRAP as an insert. AdC7 and AdC9 elicited strong immunogenicity (∼20% of CD8+ T cells in spleen), equivalent to or outperforming AdH5 and inducing sterile protection in 92% (C9), 83% (H5 and C7) and 67% (C6) of the mice, providing the first evidence of single‐dose protection to Plasmodium berghei. Protection was afforded by the SAd despite high levels of pre‐existing immunity to AdH5. Phenotypic analysis showed that all adenoviral vectors (Ad) elicited CD8+ T cell responses with an effector memory T cell (TEM) phenotype. By contrast, vaccination with poxviral vectors did not confer protection to P. berghei and induced a predominantly CD8+ central memory T cell (TCM) response. Multifunctional CD8+ T cell responses (co‐expressing IFN‐γ, TNF‐α and IL‐2) were also induced by the Ad in higher percentages than the poxviral vectors. Our data suggest that TEM cells are important as a first line of defense against fast‐replicating pathogens such as murine Plasmodium and demonstrate the potential of replication‐defective SAd as future malaria vaccines for humans.Keywords
This publication has 34 references indexed in Scilit:
- Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccinesBlood, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- Efficacy of Severe Acute Respiratory Syndrome Vaccine Based on a Nonhuman Primate Adenovirus in the Presence of Immunity Against Human AdenovirusHuman Gene Therapy, 2006
- Properties of murine CD8+CD27- T cellsEuropean Journal of Immunology, 2005
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Characterization of a Family of Chimpanzee Adenoviruses and Development of Molecular Clones for Gene Transfer VectorsHuman Gene Therapy, 2004
- Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T CellsJournal of Experimental Medicine, 2004
- Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersVaccine, 2003
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Protection against malaria by vaccination with sporozoite surface protein 2 plus CS proteinScience, 1991